Sharechat Logo

Abano expects 1H to drop as much as 14%, flagging weaker Australian economy

Monday 2nd November 2015

Text too small?

Abano Healthcare, the listed medical and dental centre investor, expects first half earnings to decline as much as 14 percent as an expanding exposure to the cooling Australian economy weighs, even as its dental network grows and audiology unit improves. 

Net profit in the six months ending November 30 is expected to be between $3 million and $3.6 million, down from $3.5 million a year earlier, the Auckland based company told shareholders at its annual meeting. Gross sales will be between $150 million and $154 million, little changed from $153.2 million. 

"The year on year comparison reflects the growth of our dental networks and the improvements in audiology, while the divestment of the pathology and orthotics businesses last year means there are no longer earning contributions from these businesses in this financial period," incoming chief executive Richard Key said in speech notes lodged with the NZX. "A like for like comparison for HY15, excluding the pathology and orthotics businesses which were sold, has been provided to give you further clarity on the relative performance of Abano’s ongoing businesses"

Abano sold its orthotics business in November last year, reasoning the exposure to government contracts wasn't compatible with Abano's investment criteria to operate on a fee for service basis. It also divested its Aotea Pathology unit after quitting the lower North Island district healthboard tender process.

Stripping out earnings from the orthotics and pathology units, profit last year was $1.9 million on gross sales of $132.7 million. 

The sales of the two businesses transformed Abano into more of an offshore business, with the company telling shareholders today that more than 60 percent of gross revenue will be generated outside New Zealand, especially from Australia. Keys warned that tough economic conditions across the Tasman, where the mining boom is winding down, will impact on sales. 

"We are facing more challenging economic conditions in Australia where economic growth is below trend, particularly in Queensland where 40 percent of our practices are based," Keys said. "Our Queensland practices are offsetting the positive same store growth we are achieving with our practices in all the other states with an overall drop in same store sales for Maven Dental Group of approximately 3 percent."

Earnings before interest, tax, depreciation and amortisation, will be between $12.5 million and $13.7 million, down from $15.4 million it reported, but up from $11 million on a continuing business basis. 

Abano shares fell 0.5 percent to $8.25 and have gained 7 percent since the start of the year. 

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

SML - Synlait Milk Limited - Trading Halt of Securities
AIA - Auckland Airport announces board chair changes
AIA - Auckland Airport announces board chair changes
CEN - Tauhara commissioning progress update
FPH initiates voluntary limited recall
March 28th Morning Report
KFL Celebrates 20 Years of Excellence in Investment Mgmt.
SVR - Savor FY24 Earnings Guidance & Change in Banking Partner
NZK - NZ King Salmon Investments Limited FY24 Results
March 27th Morning Report